Showing results (2131-2140 of 10,003) with videos related to

Sort By:
Pageof 1,001
Leukemia & Lymphoma|January 18, 2018
Efficacy and safety of frontline rituximab, cyclophosphamide, doxorubicin and prednisone plus bortezomib (VR-CAP) or vincristine (R-CHOP) in a subset of newly diagnosed mantle cell lymphoma patients medically eligible for transplantation in the randomized, phase 3 LYM-3002 studyJohannes Drach, Huiqiang Huang, Olga Samoilova, et al.
Leukemia & Lymphoma|January 19, 2018
A role for bone turnover markers β-CrossLaps (CTX) and amino-terminal propeptide of type I collagen (PINP) as potential indicators for disease progression from MGUS to multiple myelomaSonia Vallet, Nicholas R Hoyle, Robert A Kyle, et al.
Leukemia & Lymphoma|January 19, 2018
Bone marrow VEGFC expression is associated with multilineage dysplasia and several prognostic markers in adult acute myeloid leukemia, but not with survivalVicent Guillem, Marisa Calabuig, Salut Brunet, et al.
Leukemia & Lymphoma|December 8, 2017
Genetic polymorphisms of arylamine N-acetyltransferases 1 and 2 and the likelihood of developing pediatric acute lymphoblastic leukemiaOswaldo Hernández-González, Juan José Ortiz-Zamudio, Cristian Jazmín Rodríguez-Pinal, et al.
Leukemia & Lymphoma|January 4, 2018
Favorable immune signature in CLL patients, defined by antigen-specific T-cell responses, might prevent second skin cancersJuliane Sarah Walz, Daniel Johannes Kowalewski, Linus Backert, et al.
Leukemia & Lymphoma|January 12, 2018
PI3K/AKT/mTOR pathway in multiple myeloma: from basic biology to clinical promiseVijay Ramakrishnan, Shaji Kumar
Leukemia & Lymphoma|December 19, 2017
DNA damage response-initiated cytokine secretion in bone marrow stromal cells promotes chemoresistance of myeloma cellsHailong Tang, Mimi Shu, Bo Dai, et al.
Leukemia & Lymphoma|December 5, 2017
Low dose anti-thymocyte globulin reduces chronic graft-versus-host disease incidence rates after matched unrelated donor transplantationAnand Tandra, Fahrettin Covut, Brenda Cooper, et al.
Leukemia & Lymphoma|December 5, 2017
Molecular genetic profile in BCR-ABL1 negative pediatric B-cell acute lymphoblastic leukemia can further refine outcome prediction in addition to that by end-induction minimal residual disease detectionSanjeev Kumar Gupta, Sameer Bakhshi, Anita Chopra, et al.
Leukemia & Lymphoma|March 1, 2018
Diagnostic accuracy and interobserver agreement of contrast-enhanced ultrasound in the evaluation of residual lesions after treatment for malignant lymphoma and testicular cancer: a retrospective pilot study in 52 patients.Anke Peil-Grun, Corinna Trenker, Konrad Görg, et al.
Pageof 1,001